A two-story penthouse in the forthcoming Roche Bobois St. Pete Tower has sold for $13.2 million, according to an announcement from the developer. The 4,840-square-foot property brought in $2,727 per ...

The two-story penthouse in a luxury branded downtown St. Petersburg condo tower has set a new regional price record.

Downtown St. Petersburg got a big pop of color over the weekend. Why it matters: The pink paint job on several vacant ...

Four buildings on the corner of 4th St. S and 4th Ave. S in downtown St. Petersburg got a bright pink makeover ahead of ...

Turk selected the collection’s three fabric designs, pairing them with her favorite Santa Barbara Umbrella colors, trims, and silhouettes to create the shading beauties available at the Trina Turk ...

Buckhead Village welcomes Roche Bobois, bringing high-end French furniture and home accessories to Atlanta’s luxury corridor.

Roche Holding AG (VTX:ROG) recently posted some strong earnings, and the market responded positively. We have done some analysis, and we found several positive factors beyond the profit numbers. AI is ...

JIANG LIN AND ANOTHER SUSPECT GOT TO THE HOME, THEY WERE ARRESTED. CIRCLE FURNITURE IS FILING FOR BANKRUPTCY. THE COMPANY HAD SEVERAL LOCATIONS IN MASSACHUSETTS AND ONE IN PORTSMOUTH. ALL CIRCLE ...

Roche Holding AG reported its financial results for the fourth quarter of 2025, revealing a mixed performance. The company missed earnings expectations with an EPS of 8.37, falling short of the ...

Yikes! Former pro cyclist Nicolas Roche said he was violently assaulted during an attempted street robbery in Barcelona. It’s an incident he described as the “biggest fright” he has ever experienced.

Roche Holding AG subsidiaries have settled their patent suit over Shanghai Henlius Biotech Inc. and Organon & Co.'s biosimilar version of the blockbuster breast-cancer drug Perjeta, the companies said ...

Drugmakers Roche and Sanofi posted full-year earnings that matched expectations and did little to move either stock. As pharma companies face a "patent cliff" where existing drugs lose exclusivity, ...